NSCLC molecular testing in Central and Eastern European countries

BACKGROUND: The introduction of targeted treatments for subsets of non-small cell lung cancer (NSCLC) has highlighted the importance of accurate molecular diagnosis to determine if an actionable genetic alteration is present. Few data are available for Central and Eastern Europe (CEE) on mutation ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryska, Ales, Berzinec, Peter, Brcic, Luka, Cufer, Tanja, Dziadziuszko, Rafal, Gottfried, Maya, Kovalszky, Ilona, Olszewski, Włodzimierz, Oz, Buge, Plank, Lukas, Timar, Jozsef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845184/
https://www.ncbi.nlm.nih.gov/pubmed/29523116
http://dx.doi.org/10.1186/s12885-018-4023-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845184/
https://www.ncbi.nlm.nih.gov/pubmed/29523116
http://dx.doi.org/10.1186/s12885-018-4023-4

Ejemplares similares